Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Pablo Sarobe"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTEfficacy of cancer immunotherapies relies on correct recognition of tumor antigens by lymphocytes, eliciting thus functional responses capable of eliminating tumor cells. Therefore, important efforts have been carried out in antigen identific
Externí odkaz:
https://doaj.org/article/c6814b50000f44d59d15719a8a8fda2c
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/3f64f774091d469aaf67272d8e3d336d
Autor:
Belén Aparicio, Marta Ruiz, Noelia Casares, Leyre Silva, Josune Egea, Patricia Pérez, Guillermo Albericio, Mariano Esteban, Juan García-Arriaza, Juan J. Lasarte, Pablo Sarobe
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/3f530582438844589d1f5450ea62cfdf
Autor:
Belén Aparicio, Marta Ruiz, Noelia Casares, Leyre Silva, Josune Egea, Patricia Pérez, Guillermo Albericio, Mariano Esteban, Juan García-Arriaza, Juan J. Lasarte, Pablo Sarobe
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Current vaccines against SARS-CoV-2, based on the original Wuhan sequence, induce antibodies with different degrees of cross-recognition of new viral variants of concern. Despite potent responses generated in vaccinated and infected individuals, the
Externí odkaz:
https://doaj.org/article/d6eeb1262c3448e28351a2b77e173722
Autor:
Belén Aparicio, David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva, Enric Vercher, Patrick Theunissen, Ibon Tamayo, Cristian Smerdou, Ana Igea, Marta Santisteban, Cristina Gónzalez-Deza, Juan J. Lasarte, Sandra Hervás-Stubbs, Pablo Sarobe
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Immune checkpoint inhibitor (ICI)-based immunotherapy in triple negative breast cancer (TNBC) is achieving limited therapeutic results, requiring the development of more potent strategies. Combination of ICI with vaccination strategies would enhance
Externí odkaz:
https://doaj.org/article/3a2ee2360ef7461b9bdbb51a0147e8e8
Autor:
David Repáraz, Marta Ruiz, Leyre Silva, Belén Aparicio, Josune Egea, Elizabeth Guruceaga, Daniel Ajona, Yaiza Senent, Enrique Conde, Flor Navarro, Sergio Barace, Diego Alignani, Sandra Hervás-Stubbs, Juan José Lasarte, Diana Llopiz, Pablo Sarobe
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Vaccination using optimized strategies may increase response rates to immune checkpoint inhibitors (ICI) in some tumors. To enhance vaccine potency and improve thus responses to ICI, we analyzed the gene expression profile of an immunosuppressive den
Externí odkaz:
https://doaj.org/article/53cc78736e214f2f9fa14856330d5191
Autor:
Belén Aparicio, Noelia Casares, Josune Egea, Marta Ruiz, Diana Llopiz, Sheila Maestro, Cristina Olagüe, Gloria González-Aseguinolaza, Cristian Smerdou, Ascensión López-Díaz de Cerio, Susana Inogés, Felipe Prósper, José R. Yuste, Francisco Carmona-Torre, Gabriel Reina, Juan J. Lasarte, Pablo Sarobe
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1931-1946 (2021)
Identification of relevant epitopes is crucial for the development of subunit peptide vaccines inducing neutralizing and cellular immunity against SARS-CoV-2. Our aim was the characterization of epitopes in the receptor-binding domain (RBD) of SARS-C
Externí odkaz:
https://doaj.org/article/e9377e08089748589b0baa3afce49ead
Autor:
Kathrin Heim, Maike Hofmann, Robert Thimme, Marta Ruiz, Pablo Sarobe, Sandra Hervás-Stubbs, Bruno Sangro, Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, Maria Tagliamonte, David Repáraz, Enric Vercher, Diana Llopiz, Leyre Silva, Belén Aparicio, Josune Egea, Ibon Tamayo-Uria, Jorge García-Balduz, Carla Castro, Mercedes Iñarrairaegui, Charlotte Rohrer, Catrin Tauber
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/e75aa63eaad841d5bb0638f521590de1
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 4, p 2022 (2022)
Immune checkpoint inhibitors (ICI) have been used as immunotherapy for hepatocellular carcinoma (HCC) with promising but still limited results. Identification of immune elements in the tumor microenvironment of individual HCC patients may help to und
Externí odkaz:
https://doaj.org/article/a873c3b7fb44456c9baca7d51d618427
Autor:
Teresa Lozano, Silvia Chocarro, Celia Martin, Aritz Lasarte-Cia, Cynthia del Valle, Marta Gorraiz, Patricia Sarrión, Marina Ruiz de Galarreta, Amaia Lujambio, Sandra Hervás-Stubbs, Pablo Sarobe, Noelia Casares, Juan J. Lasarte
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Adoptive immunotherapy with ex vivo-expanded tumor-infiltrating lymphocytes (TILs) has achieved objective clinical responses in a significant number of patients with cancer. The failure of many patients to develop long-term tumor control may be, in p
Externí odkaz:
https://doaj.org/article/4b924afc377645edac5a48967c86c9d7